Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data.

Authors:
Yang Liu
Yang Liu
Chinese PLA General Hospital
China
Hui Bai
Hui Bai
Nanjing Medical University
China
Shunchang Jiao
Shunchang Jiao
Chinese PLA General Hospital
China

Sci Rep 2019 Apr 19;9(1):6301. Epub 2019 Apr 19.

Department of Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing, 100853, China.

Dysregulated intratumoral immune reactions are shaped by complex networks of cytokines, which coordinate with tumor cells to determine tumor progression and aggressiveness. In lung adenocarcinoma (LUAD), the role of intratumoral cytokine gene expression for stratifying prognosis has not been systematically investigated. Using high-dimensional datasets of cancer specimens from clinical patients in The Cancer Genome Atlas (TCGA), we explored the transcript abundance and prognostic impact of 27 clinically evaluable cytokines in 500 LUAD tumor samples according to clinicopathological features and two common driver mutations (EGFR and KRAS). We found that reduced expression of IL12B presented as the single prognostic factor for both poor overall survival (OS) and recurrence free survival (RFS) with high hazard ratios. Moreover, we identified that elevated expression of IL6, CXCL8 and CSF3 were additional independent predictors of poor RFS in LUAD patients. Their prognostic significance was further strengthened by their ability to stratify within clinicopathological factors. Notably, we prioritized high risk cytokines for patients with or without mutations in EGFR and KRAS. Our results provide integrative associations of cytokine gene expression with patient survival and tumor recurrence and demonstrate the necessity and validity of relating clinicopathological and genetic disposition factors for precise and personalized disease prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-42345-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474906PMC
April 2019
1 Read

Publication Analysis

Top Keywords

lung adenocarcinoma
8
egfr kras
8
gene expression
8
cytokine gene
8
prognostic significance
8
mutations egfr
8
expression
5
prognostic factor
4
factor poor
4
poor survival
4
single prognostic
4
presented single
4
reduced expression
4
expression il12b
4
il12b presented
4
survival recurrence
4
free survival
4
ratios identified
4
identified elevated
4
elevated expression
4

References

(Supplied by CrossRef)
Article in International Journal of Molecular Sciences
Kentaro Inamura et al.
International Journal of Molecular Sciences 2018
Article in Surg Oncol
C Perez-Ramirez et al.
Surg Oncol 2017
Article in J Thorac Oncol
WD Travis et al.
J Thorac Oncol 2011
Article in Front Immunol
A Albini et al.
Front Immunol 2018
Article in Front Biosci (Landmark Ed)
W Chen et al.
Front Biosci (Landmark Ed) 2011
Article in J Thorac Oncol
RL Toonkel et al.
J Thorac Oncol 2010
Article in Biomed Res Int
L Islas-Vazquez et al.
Biomed Res Int 2015
Article in Clin Cancer Res
K Suzuki et al.
Clin Cancer Res 2011
Article in Transl Oncol
I Catacchio et al.
Transl Oncol 2018
Article in Carcinogenesis
MS Shiels et al.
Carcinogenesis 2017
Article in Br J Cancer
N Sunaga et al.
Br J Cancer 2014

Similar Publications